Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Regeneron Pharmaceuticals Inc (REGN)  
$1,051.03 0.17 (0.02%) as of 4:30 Fri 6/28


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 104,690,000
Market Cap: 110.03(B)
Last Volume: 750,617 Avg Vol: 759,306
52 Week Range: $692.45 - $1071.19
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Biotechnology

Member Indexes:
    S&P COMPOSITE 1500     NASDAQ BIOTECHNOLOGY
    NASDAQ COMPOSITE     S&P SMALLCAP 600
    NASDAQ NNM COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  150
Guru Rank Value     : 6.9
Guru Occurances    : 2

 

            6 Months   1 Year   2 Year  
 
Company Profile   Regeneron Pharmaceuticals is a biotechnology company that discovers, invents, develops, manufactures, and commercializes medicines for serious diseases. Co.'s products include: EYLEA (aflibercept) Injection, which is used for the treatment of neovascular age-related macular degeneration, diabetic macular edema, macular edema following retinal vein occlusion, myopic choroidal neovascularization, diabetic retinopathy, and neovascular glaucoma; REGEN-COV, which is used for the treatment of COVID-19; and Kevzara (sarilumab) Solution for Subcutaneous Injection, which is used for the treatment of rheumatoid arthritis.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 192,108 255,165 311,759 469,743
Total Sell Value $188,697,290 $247,812,013 $294,950,701 $405,465,351
Total People Sold 7 14 16 18
Total Sell Transactions 18 43 67 128
End Date 2024-03-31 2023-12-29 2023-06-30 2022-06-30

   
Records found: 2430
  Page 47 of 98  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Sanofi-Aventis 10% Owner   –       –       •   2016-01-12 4 B $453.89 $39,034,660 I/I 83,938 23,192,508 1.5     -
   Vagelos P Roy Chairman of the Board   •       •      –    2016-01-04 4 GD $0.00 $0 I/I 387 153,548     -
   Mccorkle Douglas S VP Controller and Asst Treasur   •       –      –    2015-12-29 4 AS $552.08 $2,182,924 D/D (3,954) 6,866     -
   Mccorkle Douglas S VP Controller and Asst Treasur   •       –      –    2015-12-29 4 OE $52.03 $205,727 D/D 3,954 10,820     -
   Yancopoulos George President and CSO   •       •      –    2015-12-17 4 GA $0.00 $0 I/I 1,921 569,897     -
   Yancopoulos George President and CSO   •       •      –    2015-12-17 4 GD $0.00 $0 D/D 1,921 500,000     -
   Aberman Michael S SVP Strategy Investor Relation   •       –      –    2015-12-17 4 OE $24.00 $96,000 D/D 4,000 16,498     -
   Yancopoulos George President Regeneron Laboratori   •       •      –    2015-12-16 4 OE $52.03 $99,950 D/D 1,921 501,921     -
   Powchik Peter SVP Clinical Development & Reg   •       –      –    2015-12-16 4 OE $52.03 $99,950 D/D 1,921 17,742     -
   Mccorkle Douglas S VP Controller and Asst Treasur   •       –      –    2015-12-16 4 OE $52.03 $99,950 D/D 1,921 6,866     -
   Stahl Neil EVP Research and Development   •       –      –    2015-12-16 4 OE $52.03 $99,950 D/D 1,921 27,594     -
   Van Plew Daniel P SVP & General Mgr Industrial O   •       –      –    2015-12-16 4 OE $52.03 $99,950 D/D 1,921 1,921     -
   Brown Michael S Director   –       •      –    2015-12-10 4 AS $543.55 $1,639,365 D/D (3,000) 0     -
   Brown Michael S Director   –       •      –    2015-12-10 4 OE $177.82 $533,460 D/D 3,000 3,000     -
   Yancopoulos George President Regeneron Laboratori   •       •      –    2015-12-02 4 AS $542.72 $23,799,539 D/D (43,348) 500,000     -
   Vagelos P Roy Chairman of the Board   •       •      –    2015-11-19 4 GD $0.00 $0 D/D 1,731 332,880     -
   Sing George L Director   –       •      –    2015-11-18 4 S $580.00 $290,000 I/I (500) 4,500     -
   Sing George L Director   –       •      –    2015-11-18 4 S $580.00 $1,740,000 D/D (3,000) 112,772     -
   Sing George L Director   –       •      –    2015-11-18 4 OE $19.69 $59,070 D/D 3,000 115,772     -
   Vagelos P Roy Chairman of the Board   •       •      –    2015-11-18 4 S $586.73 $10,135,312 D/D (17,240) 334,611     -
   Yancopoulos George President Regeneron Laboratori   •       •      –    2015-11-16 4 GD $0.00 $0 I/I 1,612 567,976     -
   Van Plew Daniel P SVP & General Mgr Industrial O   •       –      –    2015-11-10 4 S $551.45 $2,842,520 D/D (5,123) 0     -
   Stahl Neil EVP Research and Development   •       –      –    2015-11-09 4 S $558.37 $12,377,559 D/D (22,101) 22,029     -
   Van Plew Daniel P SVP & General Mgr Industrial O   •       –      –    2015-11-06 4 D $559.49 $3,392,188 D/D (6,063) 5,123     -
   Van Plew Daniel P SVP & General Mgr Industrial O   •       –      –    2015-11-06 4 OE $30.63 $342,627 D/D 11,186 8,097     -
  2430 Records found
  Previous  40  41  42  43  44  45  46  47  48  49  Next   
  Page 47 of 98
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us